Related by context. All words. (Click for frequent words.) 66 TGFBR1 * 6A 64 HNPCC 64 familial pancreatic cancer 63 molecular subtypes 63 MGUS 62 BRCA2 mutations 62 susceptibility loci 62 nonmelanoma skin cancers 62 genetic variants associated 61 Li Fraumeni 61 inherited mutations 61 genetic loci 61 IgA deficiency 61 somatic mutations 61 microdeletions 61 meningiomas 61 renal cell carcinomas 61 BRCA mutation 60 advanced neoplasia 60 mesotheliomas 60 sCJD 60 lung adenocarcinomas 60 #q# deletion 60 TACI mutations 60 Hurthle cell 60 MYH9 gene 60 myeloproliferative neoplasms 60 obstructive coronary artery 60 causative mutations 60 causal variants 60 narcolepsy cataplexy 60 sporadic ALS 60 BRCA1 mutations 60 CDH1 59 pilocytic astrocytomas 59 genetic abnormalities 59 malignant neoplasm 59 adenomatous polyps 59 carcinoid 59 colorectal cancer CRC 59 precursor lesions 59 BRCA2 carriers 59 ovarian endometrial 59 prognostic markers 59 missense mutations 59 aneuploidies 59 LTBI 59 thyroid nodules 59 breast carcinomas 58 leukaemias 58 hereditary breast cancer 58 neurologic complications 58 pulmonary metastases 58 Thyroid nodules 58 diffuse gastric 58 ADPKD 58 pituitary adenomas 58 systemic scleroderma 58 BRCA mutations 58 benign proliferative breast 58 germline mutations 58 ccRCC 58 gynecologic malignancy 58 atypical hyperplasia 58 susceptibility genes 58 endometrial cancers 58 familial adenomatous polyposis 58 modifier genes 58 curable cancers 58 histological subtype 58 hereditary predisposition 58 Squamous 58 pancreatic adenocarcinoma 58 monoclonal gammopathy 58 PCNSL 58 chorioamnionitis 58 hypermethylated 58 NP CRNs 58 colorectal neoplasms 58 benign moles 58 Li Fraumeni syndrome 57 ApoE4 gene 57 pathogenic mutations 57 breast endometrial 57 molecular abnormalities 57 mammographically 57 BRCA1 mutation carriers 57 neuroblastoma tumors 57 familial adenomatous polyposis FAP 57 #q#.# [001] 57 genetic syndromes 57 prostate cancer CaP 57 methylation markers 57 genetic aberrations 57 TCF#L# gene 57 de novo mutations 57 EGFR mutation status 57 neoplasias 57 etiologic 57 nonalcoholic steatohepatitis 57 APOE e4 57 serous ovarian cancer 57 varicella infection 57 Colon polyps 57 polycystic ovarian syndrome PCOS 57 carcinoid tumors 57 genomic alterations 57 latent TB infection 57 chromosome abnormality 57 seminomas 57 CA MRSA infections 57 stratifying patients 57 breast cancer subtypes 57 mtDNA mutations 57 histologic subtype 57 Leukemias 57 molecular biomarkers 57 supratentorial 57 neuro degenerative disorder 57 malignant lesions 57 allele frequencies 57 KRAS oncogene 57 nonmelanoma 57 hematopoietic cancers 57 human metapneumovirus 56 ependymomas 56 HNSCC 56 familial clustering 56 epithelial tumors 56 microsatellite instability 56 GBA mutations 56 BRCA2 mutation 56 nodal metastasis 56 endophenotypes 56 CHDs 56 ARVD 56 postoperative pathology 56 deCODE BreastCancer TM 56 thrombophilia 56 testicular germ cell 56 basal cell nevus syndrome 56 clinicopathologic 56 genomic markers 56 node metastases 56 ORMDL3 56 Brugada syndrome 56 histological subtypes 56 smoldering myeloma 56 KRAS mutations 56 androgen deficiency 56 benign polyps 56 chromosomal alterations 56 Autoimmune diseases 56 HER2 overexpression 56 DNA rearrangements 56 inherited predisposition 56 vCJD epidemic 56 ASCUS 56 nonmelanoma skin cancer 56 tumor subtypes 56 NNRTI resistance 56 microvascular disease 56 genes BRCA1 56 advanced adenoma 56 invasive carcinoma 56 ZNF# 56 pre cancerous polyps 56 chromosomal disorders 56 lymph node metastases 56 spontaneous regression 56 Kufs disease 56 grade serous ovarian 56 faulty BRCA2 gene 56 BRAC2 56 Epstein Barr virus EBV 56 BRCA mutation carriers 56 pre malignant lesions 56 BRCA2 gene mutations 56 susceptibility gene 56 unexplained mental retardation 56 carotid stenosis 56 APOE genotype 56 Genetic variants 56 advanced adenomas 56 familial aggregation 56 causative mutation 56 contralateral breast cancer 56 noncardiac 56 genetic determinants 56 fragility fractures 56 HER2 expression 56 GPC5 55 JAK mutations 55 distinct subtypes 55 MYH9 55 squamous cell lung cancer 55 BMPR2 55 GBMs 55 p# biomarker 55 gastric carcinoma 55 Plasmodium vivax 55 astrocytomas 55 clinically heterogeneous 55 microbleeds 55 white matter hyperintensities 55 pancreatic cancers 55 de ath 55 thoracic aortic disease 55 familial ALS 55 nonhereditary 55 poor metabolizers 55 salivary proteins 55 medulloblastomas 55 elevated CRP 55 ependymoma 55 XMRV infection 55 basal cell carcinoma BCC 55 subclinical atherosclerosis 55 chronic periodontitis 55 gastric cancers 55 metastatic lesions 55 subclinical hyperthyroidism 55 Cholangiocarcinoma 55 CHD CVD 55 herpesviruses 55 NAFLD 55 causative genes 55 Endometrial cancer 55 transfusion syndrome 55 genetic polymorphisms 55 proband 55 chlamydial infection 55 cardioembolic stroke 55 APOL1 55 DNA methylation patterns 55 atherothrombotic disease 55 HG PIN 55 splice junctions 55 TP# mutation 55 extracolonic findings 55 invasive ductal breast cancer 55 LRRK2 gene 55 HPV subtypes 55 morphologic 55 leiomyomas 55 hypercoagulable 55 K ras mutations 55 breast cancer gene mutation 55 malignant pleural mesothelioma 55 gene APOE4 55 GBM tumors 55 EBV infection 55 #p# [001] 55 muscular dystrophy cystic fibrosis 55 clefting 55 fronto temporal dementia 55 hematological disorders 55 faulty BRCA genes 55 Malignant tumors 55 cancers 55 elevated triglyceride levels 55 PCA3 gene 55 immunodeficiencies 55 poorer prognosis 55 carcinoid tumor 55 LRRK2 mutations 55 precancer 55 genomewide association studies 55 G6PD deficiency 55 #q# [001] 55 sentinel nodes 55 Ebola Hemorrhagic Fever 55 untreated celiac disease 55 EoE 55 Aortic stenosis 55 myeloproliferative disorders 55 spontaneous mutations 55 medulloblastoma tumors 55 colorectal polyps 55 nasopharyngeal carcinoma 55 Basal cell 55 #q#.# deletion syndrome 54 KRAS mutation 54 ovarian malignancy 54 Chronic lymphocytic leukemia 54 histologies 54 lysosomal storage diseases 54 undiagnosed celiac disease 54 premalignant lesions 54 acute leukemias 54 genetic markers 54 HER2 gene 54 lobular carcinoma 54 familial hypercholesterolemia 54 sporadic Creutzfeldt Jakob 54 Valvular heart 54 Chronic pancreatitis 54 HPV genotypes 54 radiographic findings 54 proximal colon 54 microscopic colitis 54 hyperplastic 54 Hurler syndrome 54 micrometastases 54 metastatic brain tumor 54 invasive lobular 54 mutated BRCA1 54 osteosarcomas 54 gastric adenocarcinoma 54 invasive ductal 54 Recurrences 54 TP# mutations 54 CIN2 + 54 ALI ARDS 54 metastatic lymph nodes 54 intestinal metaplasia 54 squamous 54 Leber congenital amaurosis LCA 54 enteroviral 54 Acute myeloid leukemia 54 MRSA isolates 54 polyp recurrence 54 BRCA2 mutation carriers 54 distant metastasis 54 cystic fibrosis muscular dystrophy 54 SNP rs# [002] 54 neuroendocrine cancers 54 basal cell carcinomas 54 chromosomal anomalies 54 ovarian breast 54 Gorlin syndrome 54 skeletal metastases 54 TNF blocker therapy 54 Malignant gliomas 54 Wegener granulomatosis 54 circulating endothelial cells 54 NOMID 54 Genetic predisposition 54 Cryptococcus neoformans 54 prognostic indicators 54 pharmacogenetic tests 54 pleural mesothelioma 54 squamous cell cancers 54 grade gliomas 54 mycosis fungoides 54 Haptoglobin 54 fetal aneuploidy 54 Crigler Najjar syndrome 54 lymph node involvement 54 intestinal polyps 54 MSH2 54 GIST tumors 54 serotype #A 54 CMV infection 54 ectodermal dysplasia 54 hematological malignancy 54 hormone receptor negative 54 oncogenic HPV 54 BRAF mutation 54 chromosomal deletions 54 PTPN# 54 FGFR2 gene 54 testicular tumors 54 Lafora disease 54 prenatally diagnosed 54 PITX2 54 lysosomal diseases 54 microdeletion 54 DCIS lesions 54 atypical ductal hyperplasia 54 Vitamin D insufficiency 54 cryptogenic stroke 54 idiopathic pulmonary 54 subclinical disease 54 OnDose TM 54 spinocerebellar ataxia 54 metastatic tumors 54 multivessel coronary artery 54 malignant brain 54 dentinal hypersensitivity 54 Colorectal cancer CRC 54 S. aureus infection 54 clinically detectable 54 bladder cancers 54 EGFR mutation 54 Renal Cell Carcinoma RCC 54 gene polymorphisms 54 lung carcinomas 54 mutated K ras 54 IDH mutations 54 ovarian tumors 54 chromosome #p# [001] 54 liver transplant recipients 54 testicular cancers 54 S. maltophilia 54 EUS FNA 54 precancerous cervical 54 HER2 positive cancers 54 amnestic MCI 54 chromosome #q# [001] 54 benign lesions 54 HLA genes 54 paraganglioma 54 multisystem disease 54 cortical dysplasia 54 metastatic bladder 54 lobular cancer 54 virus XMRV 54 C. diff infections 54 neurocognitive impairment 54 VKORC1 54 intravenous bisphosphonates 54 Borrelia 54 anal HPV 54 prostate pancreatic 54 IPAH 53 nodal metastases 53 microbiomes 53 LQTS 53 epigenetic markers 53 periodontal pathogens 53 pharyngeal cancer 53 bowel polyps 53 Sporadic CJD 53 malignant polyps 53 alveolar rhabdomyosarcoma 53 chromosomal rearrangement 53 autonomic dysfunction 53 esophageal squamous cell carcinoma 53 colorectal neoplasia 53 Rectal cancer 53 BRCA carriers 53 genetic variations 53 ciliopathies 53 renal carcinoma 53 acid suppressive medication 53 APOE ε4 53 subtypes 53 pneumococcal infection 53 penetrance 53 enterotypes 53 CIN3 53 fluoroquinolone resistant 53 BRAF gene mutations 53 Genetic variations 53 Adenomas 53 PTEN mutations 53 Medullary thyroid cancer 53 AAT deficiency 53 gene BRCA2 53 causative gene 53 asymptomatic PAD 53 recessive inheritance 53 cervical lymph nodes 53 FGFR2 53 pathophysiologic 53 polycystic kidneys 53 cryptogenic 53 #q#.# [002] 53 adenoid cystic carcinoma 53 mitochondrial disorders 53 HIV HCV coinfected 53 prostate adenocarcinoma 53 K ras mutation 53 autoinflammatory diseases 53 chromosome #p#.# 53 pre cancerous 53 axillary lymph nodes 53 chromosomal defect 53 hamartomas 53 M. leprae 53 medullary thyroid cancer 53 pancreatic prostate 53 underdiagnosis 53 microcalcifications 53 clade B 53 hormonal abnormalities 53 eosinophilic esophagitis 53 CNTNAP2 53 MLL2 53 G#S mutation 53 gastrointestinal cancers 53 obstructive coronary 53 gene rearrangements 53 Pancreatic neuroendocrine tumors 53 adenocarcinomas 53 Hepatocellular Carcinoma HCC 53 hepatocellular carcinomas 53 schwannomas 53 thymoma 53 medically inoperable 53 malignancies 53 channelopathies 53 HLA DQ2 53 neurodevelopmental disorders 53 chromosomal aberrations 53 BRCA2 gene 53 Wilms tumors 53 metastatic lung cancer 53 epigenetic changes 53 tumor histology 53 SOD1 gene 53 serogroups 53 Metastases 53 BRCA1 BRCA2 53 degenerative neurological diseases 53 infantile hemangiomas 53 WNV infection 53 hepatitis C genotype 53 oligodendrogliomas 53 acute lymphoid leukemia 53 mosaicism 53 unmeasured factors 53 Basal cell carcinoma 53 intracranial hemorrhage ICH 53 T1DM 53 monogenic 53 EGFR mutations 53 nonproliferative 53 thyrotropin levels 53 orchitis 53 APOE4 53 BRAF mutations 53 biologic pathways 53 frequently benign tumor 53 TTR amyloidosis 53 Chlamydia pneumoniae 53 myelogenous leukemia 53 brain lesions 53 oropharyngeal cancer 53 BRCA2 gene mutation 53 basal cell cancers 53 kidney urologic 53 rs# [004] 53 spinal metastases 53 Uterine fibroids 53 ductal carcinomas 53 Chest x rays 53 pathogenic mechanisms 53 uterine cancers 53 retrospective cohort 53 Relapsing remitting MS 53 mutated genes 53 Langerhans cell histiocytosis 53 probands 53 genetic locus 53 Sjögren syndrome 53 premalignant 53 SLNB 53 AML MDS 53 syndromic 53 prognostic variables 53 ataxias 53 dysglycemia 53 genomewide 53 renal tumors 53 abnormal lipid 53 gonococcal infection 53 Human papilloma virus 53 Autoimmune disorders 53 paragangliomas 53 nodular melanoma 53 C. trachomatis 53 Acute lymphoblastic leukemia 53 Nonalcoholic fatty liver 53 myelofibrosis polycythemia vera 53 leukodystrophies 53 congenital toxoplasmosis 53 incidentalomas 53 neuroblastomas 53 neurological abnormalities 53 HPV# 53 microscopic lesions 53 underlying pathophysiology 53 urolithiasis 53 adrenocortical cancer 53 colorectal cancers 53 Cognitive impairment 53 lobular breast cancer 53 nonsense mutations 53 PCa 53 familial predisposition 53 FLT3 mutations 53 neoplasms 53 acute rheumatic fever 53 sickle cell cystic fibrosis 53 embryonal rhabdomyosarcoma 52 hypovitaminosis D 52 chromosomal abnormalities 52 Vitamin B# deficiency 52 gene predisposing 52 pancreatic cysts 52 microRNA molecules 52 apolipoprotein E gene 52 chronic HBV infection 52 Mendelian disorders 52 biochemical markers 52 ABCB1 52 haplotypes 52 atypia 52 Darapladib 52 urethritis 52 chromosomal defects 52 FLT3 52 respiratory viral infections 52 MLH1 52 Menopausal hormone therapy 52 colorectal polyp 52 gene variants 52 Colorectal cancers 52 carotid artery blockage 52 predisposing factor 52 Clostridium difficile infections 52 psychiatric comorbidities 52 ApoE4 52 hamartoma 52 LV dysfunction 52 Major depressive disorder 52 APOE e4 gene 52 modifiable risk 52 chromosomal regions 52 genetic variants 52 enteroviruses 52 CIN2 52 PNET 52 CSF biomarkers 52 colorectal carcinoma 52 genetic underpinnings 52 thymic carcinoma 52 androgen excess 52 precancerous cervical lesions 52 Von Willebrand disease 52 severe congenital neutropenia 52 Severe Primary IGFD 52 KIF6 gene 52 histological diagnosis 52 locoregional recurrence 52 FXTAS 52 TTR gene 52 microcephalin 52 lung colorectal 52 simplex virus 52 dominantly inherited 52 MDR tuberculosis 52 microRNA expression 52 CYP#C# [001] 52 Chronic Lyme disease 52 staphylococcal infections 52 uveal melanoma 52 underarm lymph nodes 52 Listeria infections 52 differentiated thyroid 52 melanoma lesions 52 benign growths 52 ovarian carcinomas 52 postoperative delirium 52 Candida species 52 Epithelial ovarian cancer 52 colon cancers 52 intraoperative complications 52 UGT#A# * 52 frontotemporal dementia 52 cancerous enlargement 52 IKZF1 52 antenatal depression 52 CYP#D# genotype 52 ovarian pancreatic 52 grade cervical intraepithelial 52 FTLD 52 heritable diseases 52 gallstone disease 52 breast cancer metastasis 52 super spreaders 52 neurofibroma 52 nasopharyngeal cancer 52 extramedullary 52 papillary thyroid cancer 52 congenital malformations 52 UGT#B# 52 neoplastic 52 pancreatic neuroendocrine tumors 52 nonmetastatic 52 testicular dysgenesis syndrome 52 Takotsubo cardiomyopathy 52 Chlamydia infections 52 progressive neurodegenerative disorder 52 carotid plaque 52 MC1R gene 52 LRRK2 mutation 52 endoscopic ultrasonography 52 epithelial cancers 52 pheochromocytomas 52 KRAS variant 52 HBV infection 52 Non Hodgkin lymphomas 52 autosomal dominant inheritance 52 Previous epidemiological studies 52 mucinous 52 Lung transplantation 52 chromosome aberrations 52 deCODE Glaucoma TM 52 neuroinvasive form 52 SE alleles 52 MYCN amplification 52 colorectal lung 52 malaria parasite Plasmodium falciparum 52 intensive statin therapy 52 squamous cell cancer 52 pituitary tumors 52 generalized vitiligo 52 IL#R 52 cholangiocarcinoma 52 hepatocellular carcinoma 52 CHEK2 52 benign breast 52 operable breast cancer 52 BARD1 52 lung adenocarcinoma 52 SMAD4 52 mutated KRAS gene 52 chronic bilirubin encephalopathy 52 TMPRSS2 ERG fusion 52 pituitary adenoma 52 inflammatory biomarkers 52 prediabetes 52 antiphospholipid antibodies 52 pneumococci 52 common hematologic malignancy 52 chromosome #q#.# [001] 52 STK# gene 52 breast cancer genes BRCA1 52 invasive ductal carcinomas 52 precancerous tumors 52 chlamydial infections 52 breast lesions 52 Chlamydia trachomatis 52 GISTs 52 coinfection 52 VCFS 52 phenotypic variation 52 serogroup B 52 juvenile myelomonocytic leukemia 52 SNPs 52 pulmonary metastasis 52 BRAF V#E 52 methicillin resistant staph 52 somatic mutation 52 Glioblastoma multiforme GBM 52 atypical moles 52 Uterine cancer 52 cardiomyopathies 52 endometrial hyperplasia 52 mitochondrial mutations 52 activating mutations 52 Antibiotic resistant infections 52 carotid bruit 52 malignant glioma brain tumor 52 vaccinees 52 HBeAg negative 52 histologic subtypes 52 C#Y 52 granulosa cell 52 HLA DRB1 52 splice variants 52 BCR ABL mutations 52 lung cancer NSCLC 52 carcinomas 52 Testicular cancer 52 JMML 52 Chlamydia infection 52 macrovascular events 52 PROLARIS 52 myalgic encephalomyelitis ME 52 primary biliary cirrhosis 52 distant metastases 52 non syndromic 52 urothelial carcinoma 52 Melanomas 52 HbF 52 underwent CABG 52 CYT# potent vascular disrupting 52 Krabbe Disease 52 lichen planus 52 fluoroquinolone resistance 52 genital HPV infections 52 genetic ancestry 52 fatal neuromuscular disorder 52 breast pancreatic 52 Perthes disease 52 colorectal adenomas 52 abnormal cytology 52 papillary renal cell carcinoma 52 M. pneumoniae 52 WNV infections 52 limiting generalizability 52 ductal breast cancer 52 neuro developmental disorders 52 Carcinoid tumors 52 Glioblastoma Multiforme 52 vesicoureteral reflux VUR 52 Bloodstream infections 52 cutaneous melanoma 52 lymphoid tumors 52 CDKN2A 52 metastatic melanomas 52 atypical lobular hyperplasia 52 Hypertrophic cardiomyopathy 52 susceptibility alleles 52 metastatic prostate 52 pelvic malignancies 52 #p#.# [001] 52 Gliomas 52 RMSF 52 Glioblastoma Multiforme GBM 51 breast carcinoma 51 PGDH 51 causative organism 51 juvenile idiopathic arthritis 51 precancers 51 mutations 51 chronic rhinosinusitis 51 generalized epilepsy 51 recurrent NSCLC 51 colorectal carcinomas 51 genomic variants 51 diagnose Alzheimer disease 51 bacterial prostatitis 51 pleomorphic 51 medulloblastoma malignant brain tumor 51 CNVs 51 Gastric cancer 51 prognostic biomarkers 51 influenza subtypes 51 thromboembolic disease 51 penile cancers 51 tumor recurrence 51 Tay Sachs thalassemia 51 melanoma basal cell 51 Hirschsprung disease 51 Fanconi syndrome 51 IDH1 mutation 51 comorbid disorders 51 differentially expressed genes 51 stress cardiomyopathy 51 Chronic Lymphocytic Leukemia CLL 51 estrogen progestin therapy 51 Pneumococcal pneumonia 51 olfactory dysfunction 51 rhinovirus infection 51 AKT1 mutation 51 Plaque psoriasis 51 NR#A# 51 autism susceptibility genes 51 malignant neoplasms 51 systemic lupus erythematosus SLE 51 GNAQ 51 cranial irradiation 51 etiologic factors 51 Fragile X gene 51 gonococcal 51 hematological diseases 51 lipid abnormalities 51 prostate carcinogenesis 51 ANCA associated 51 definite stent thrombosis 51 C. pneumoniae 51 occult metastases 51 etiological 51 euthymic patients 51 Squamous cell 51 immunotherapeutic approaches 51 lung pancreatic 51 neurofibromas 51 Balamuthia 51 Sezary syndrome 51 hereditary breast 51 ovarian cervical 51 gestational diabetes mellitus 51 cardiac channelopathies 51 genetic alterations 51 HGPIN 51 neuropsychological impairments 51 JAK2 mutation 51 sexually transmitted HPV 51 oropharyngeal cancers 51 underlying molecular mechanisms 51 nonalcoholic steatohepatitis NASH 51 malignant melanomas 51 PKCi 51 genital tract infections 51 uterine ovarian 51 obstructive lung 51 Framingham Risk Score 51 desmoplastic 51 superinfection 51 lymph node metastasis 51 meningitis encephalitis 51 T1a 51 diabetic kidney 51 hematologic disorders 51 maternally inherited 51 hemophagocytic lymphohistiocytosis 51 genomic deletions 51 Radical prostatectomy 51 situ LCIS 51 Polycythemia vera 51 clinicopathological 51 LRP5 51 Celiac sprue 51 breast cancer recurrences 51 gene loci 51 myocardial infarctions MIs 51 comorbid depression 51 molecular markers 51 infection progressive multifocal 51 asymptomatic carriers 51 epigenetic alterations 51 nonsmall cell lung cancer 51 chromosome translocations 51 fibrocystic 51 malignant growths 51 subclinical hypothyroidism 51 meningoencephalitis 51 hormone receptor status 51 unresectable tumors 51 monozygotic twins 51 lobular carcinomas 51 myeloproliferative diseases 51 Neurological disorders 51 CCR5 delta# 51 persistent pulmonary hypertension 51 rs# [002] 51 Yamanaka recipe 51 MECP2 gene 51 systemic lupus erythematosus 51 SSc 51 mutated BRAF gene 51 phenotypic characteristics 51 Ankylosing spondylitis 51 lung nodules 51 T2D 51 subtype 51 candidemia 51 stem cells CSCs 51 phenotypic expression 51 MELAS 51 neoplasm 51 encephalitis swelling 51 thyroid dysfunction 51 RSV infections 51 underwent surgical resection 51 repeat allele 51 invasive cervical cancer 51 CC genotype 51 abnormal lipid levels 51 lateral sclerosis ALS 51 viral etiology 51 eTag assays 51 aetiology 51 HLA markers 51 differentially expressed proteins 51 prostate bladder 51 structural abnormalities 51 PARP inhibition 51 gene mutations 51 molecularly defined 51 metabolic abnormality 51 metastatic gastric 51 malignant gliomas 51 sentinel lymph node biopsy 51 slow metabolizers 51 S.aureus 51 essential thrombocythemia 51 SNP rs# [001] 51 HCV infection 51 malignant nodules 51 miRNA genes 51 NKX2 51 randomized controlled trials RCTs 51 papillary carcinoma 51 juvenile idiopathic arthritis JIA 51 precancerous condition 51 bowel cancers 51 predisposing factors 51 precancerous polyp 51 squamous cell histology 51 sentinel lymph nodes 51 bacterium Neisseria meningitidis 51 nondiabetic 51 chronic lymphocytic 51 Trichophyton rubrum 51 FSGS 51 Postpartum psychosis 51 disease NAFLD 51 paternal lineages 51 deCODE AF TM 51 Adjuvant chemotherapy 51 Barrett mucosa 51 reverse vaccinology